secwatch.observer — SEC 8-K summary
======================================

Issuer:     Grace Therapeutics, Inc. (GRCE)
CIK:        0001444192
Form:       8-K
Filed at:   2024-10-28T23:59:59+00:00
Accession:  0001140361-24-044363
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acasti Pharma changes name to Grace Therapeutics; Nasdaq ticker becomes GRCE
----------------------------------------------------------------------------

- Name changed from Acasti Pharma Inc. to Grace Therapeutics, Inc., effective Oct 28, 2024.
- Nasdaq ticker symbol changed from ACST to GRCE on October 28, 2024.
- CUSIP number unchanged at 00439U104; no effect on shareholder rights.
- Bylaws amended only to reflect new corporate name; no other changes made.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1444192/000114036124044363/0001140361-24-044363-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1444192/000114036124044363/ef20037633_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-044363

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer